Dr. Mogali is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1051 Riverside Dr
New York, NY 10032Phone+1 646-774-6147
Education & Training
- New York Presbyterian Hospital (Columbia Campus)/New York State Psychiatric InstituteFellowship, Addiction Psychiatry, 2009 - 2011
- Emory University School of MedicineResidency, Psychiatry, 2005 - 2009
- Fisk UniversityBA, Biology, 2001 - 2005
- Meharry Medical CollegeClass of 2005
Certifications & Licensure
- NY State Medical License 2009 - 2026
- RI State Medical License 2022 - 2026
- CT State Medical License 2014 - 2025
- MA State Medical License 2014 - 2025
- GA State Medical License 2008 - 2012
- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Addiction Psychiatry
Awards, Honors, & Recognition
- Outstanding Resident Award Nominee Indo-American Psychiatric Association, 2008
- Merit Based General Endowed Scholarship 2002
Publications & Presentations
PubMed
- 2 citationsGabapentin increases the abuse liability of alcohol alone and in combination with oxycodone in participants with co-occurring opioid and alcohol use disorder.F Castillo, J D Jones, R R Luba, S Mogali, R W Foltin
Pharmacology, Biochemistry, and Behavior. 2022-11-01 - 2 citationsThe effects of acute oral naltrexone pretreatment on the abuse potential of intranasal methamphetamine, and the relationship between reward/punishment sensitivity and ...Jermaine D Jones, Mudassir Mumtaz, Nehal P Vadhan, Suky Martinez, Satadru Pramanik
Behavioural Pharmacology. 2022-06-01 - 10 citationsMinocycline attenuates oxycodone-induced positive subjective responses in non-dependent, recreational opioid users.Shanthi Mogali, Paula Askalsky, G. Madera, Jermaine D. Jones, Sandra D. Comer
Pharmacology, Biochemistry, and Behavior. 2021-10-01
Journal Articles
- Pioglitazone, a PPARy agonist, reduces nicotine craving in humans with marginal effects on abuse potentialJones JD, Comer SD, Metz VE, Manubay JM, Mogali S, Ciccocioppo R, Martinez S, Mumataz M, Bisaga A, Pharmacol Biochem Behav, 1/8/2017
- Abuse liability of intravenous buprenorphine vs buprenorphine/naloxone: Importance of absolute naloxone amountJones JD, Manubay JM, Mogali S, Metz VE, Madera G, Martines S, Mumtaz M, Comer SD, Drug Alcohol Depend, 1/1/2017
- Ab Initio Analysis of Lithium DimethylaminoborohydrideMogali S, Darville K, Pratt L, Journal of Organic Chemistry, 1/1/2001
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- The Effects of Minocycline on Oxycodone-Induced Responses.Mogali S, Paula Askalsky, Jessica Fogel, Gabriela Madera, Jermaine Jones, Maria Sullivan, Jeanne Manubay, Sandra Comer, Experimental Biology, Boston, MA, 1/20/2013
- Effects of Minocycline on Oxycodone-Induced Responses.Mogali S, Comer SD, College on Problems of Drug Dependence, San Diego, CA, 1/15/2013
- Naltrexone reduces the subjective effects of oral d-amphetamine but not smoked cocaine in humans.Mogali S, Comer SD, Saccone PA, Roux P, Jones JD, Cooper SZ, Vosburg SK, Sullivan MA Rubin E, Manubay JM, Martinez DM, Walker EA, Haney M, Foltin RW, College on Problems of Drug Dependence, Palm Spring, CA, 1/9/2012
- Join now to see all
Press Mentions
- Here's How to Know if Your Winter Blues Are More Serious Than You ThinkNovember 20th, 2017
- What Does High-Risk Drinking Really Look Like?August 24th, 2017
- What You Should Know About SAD and Chronic PainFebruary 17th, 2017
- Join now to see all
Research History
- T32 Research Fellow, Columbia University2009 - 2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: